Interactive eLearning modules
Initial Introduction of Therapy
Authored by Dr Mehta, this activity covers how to develop the most appropriate treatment plans, utilizing newer therapies and combinations, for recently diagnosed or referred individuals who may have a high risk of hypoglycemia.
Transcripts available in French, German, Italian and Spanish.
Authored by Dr Wilmot, this activity focuses on the most effective way to monitor people with diabetes, particularly focusing on the use of CGM, and when and how treatment should be adapted to reduce the risk of hypoglycemia.
Transcripts available in French, German, Italian and Spanish.
Faculty and disclosures
Consultant Diabetologist, University Hospitals of Derby and Burton NHS Foundation Trust and Honorary (consultant) Assistant Professor, University of Nottingham, Nottingham, UK
Emma Wilmot’s specialist interests include Type 1 diabetes, insulin pump therapy and diabetes technology, young adults with diabetes and antenatal diabetes care.
Dr Wilmot is chair of the ABCD Diabetes Technology Network UK. In this role she leads the delivery of a program of educational events for multidisciplinary diabetes teams. She has led the development of a suite of national ‘best practice’ guides related to insulin pump therapy and is a member of the National Diabetes Audit Insulin Pump Expert Reference Group, developing the 2018 national Type 1 diabetes service level audit. Dr Wilmot has been involved in the #language matters movement which aims to improve healthcare professional communication with people with diabetes.
Dr Wilmot was awarded the University of Leicester medal for excellent PhD performance in 2013 for her PhD “Type 2 diabetes in younger adults”.
Disclosures
Personal fees from Abbott Diabetes Care, Dexcom, Diasend, Eli Lilly, Medtronic, Novo Nordisk, Sanofi Aventis.
Metabolic Diseases Research Unit (UIEM), Department of Endocrinology, National Institute of Medical Sciences and Nutrition Salvador Zubirán, Mexico City, Mexico
Roopa Mehta is an endocrinologist and researcher in the Department of Endocrinology and Metabolism at the INCMNSZ. She is the director of the lipid clinic and the cardiovascular laboratory in this hospital. She is an associate professor in both pre- and postgraduate endocrinology programs, and is a principal investigator for phase 3 clinical trials. Dr Mehta undertook her medical training at the United Medical and Dental Schools of Guy’s and St Thomas’ Hospitals, London, UK. She subsequently trained as an endocrinologist at the INCMNSZ. On completing the residency program, Dr Mehta subspecialized in diabetes and metabolism and gained further clinical and investigative experience rotating at the Joslin Diabetes Center, Boston, MA, USA. She holds a masters degree in medical sciences from the National Autonomous University of Mexico and is currently completing her doctorate.
Dr Mehta’s research interests focus on Type 2 diabetes mellitus (clinical investigation), metabolic syndrome and dyslipidemia. She has received the Alfonso Rivera Research Award and the Young Investigator Award from the AACE. Dr Mehta has authored and co-authored publications in international journals in addition to numerous book chapters. She is a co-editor of a book for patients – “Living with Diabetes: A Practical Manual”.
Disclosures
Roopa Mehta declares honoraria and/or consultation fees from Novo Nordisk, Abbott, AstraZeneca, Amgen, Boehringer Ingelheim, Eli Lilly, Sanofi, and Janssen.
Accreditation
In support of improving patient care, this activity has been planned and implemented by North American Center for Continuing Medical Education (NACCME) and Springer Healthcare IME. NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Translations
Transcripts are available inside the eLearning modules in French, German, Italian, and Spanish.
